Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Hanahan

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Genes & Development|November 23, 2006
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerNabeel Bardeesy, Kuang-Hung Cheng, Justin H Berger, et al.
Neoplasia (New York, N.Y.)|July 2, 2013
Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detectionEdmund J Keliher, Thomas Reiner, Sarah Earley, et al.
Nature|September 20, 2019
Synaptic proximity enables NMDAR signalling to promote brain metastasisQiqun Zeng, Iacovos P Michael, Peng Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Dendritic cells in human thymus and periphery display a proinsulin epitope in a transcription-dependent, capture-independent fashionCarlos A Garcia, Kamalaveni R Prabakar, Juan Diez, et al.
Cancer Cell|April 3, 2018
GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor GrowthLeanne Li, Qiqun Zeng, Arjun Bhutkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2011
Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific mannerLiang Xie, Michael B Duncan, Jessica Pahler, et al.
Nature Reviews. Cancer|June 29, 2026
Imaging the hallmarks of cancerJan Grimm, Fabian Kiessling, Kevin M Brindle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseNabeel Bardeesy, Andrew J Aguirre, Gerald C Chu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoringDonald M McDonald, Beverly A Teicher, William Stetler-Stevenson, et al.
Cancer Discovery|October 9, 2015
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic CharacteristicsAnguraj Sadanandam, Stephan Wullschleger, Costas A Lyssiotis, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Genes & Development|November 23, 2006
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerNabeel Bardeesy, Kuang-Hung Cheng, Justin H Berger, et al.
Neoplasia (New York, N.Y.)|July 2, 2013
Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detectionEdmund J Keliher, Thomas Reiner, Sarah Earley, et al.
Nature|September 20, 2019
Synaptic proximity enables NMDAR signalling to promote brain metastasisQiqun Zeng, Iacovos P Michael, Peng Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Dendritic cells in human thymus and periphery display a proinsulin epitope in a transcription-dependent, capture-independent fashionCarlos A Garcia, Kamalaveni R Prabakar, Juan Diez, et al.
Cancer Cell|April 3, 2018
GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor GrowthLeanne Li, Qiqun Zeng, Arjun Bhutkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2011
Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific mannerLiang Xie, Michael B Duncan, Jessica Pahler, et al.
Nature Reviews. Cancer|June 29, 2026
Imaging the hallmarks of cancerJan Grimm, Fabian Kiessling, Kevin M Brindle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseNabeel Bardeesy, Andrew J Aguirre, Gerald C Chu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoringDonald M McDonald, Beverly A Teicher, William Stetler-Stevenson, et al.
Cancer Discovery|October 9, 2015
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic CharacteristicsAnguraj Sadanandam, Stephan Wullschleger, Costas A Lyssiotis, et al.
Pageof 11